Clinical Application Guidelines on Chinese Patent Medicine in Treatment of Ulcerative Colitis (Condensed Edition, 2022) / 胃肠病学
Chinese Journal of Gastroenterology
;
(12): 17-26, 2023.
Artículo
en Chino
| WPRIM
| ID: wpr-1016045
ABSTRACT
Ulcerative colitis (UC) is a dominant disease that can be treated with traditional Chinese medicine, and Chinese patent medicine is an important part of traditional Chinese medicine. However, there are still many cases of non-standard drug use in the clinical treatment of UC. Clinical Application Guidelines for Dominant Diseases Treated with Chinese Patent Medicine Standardization Project Team convened experts on traditional Chinese medicine, Western medicine, pharmacology, and methodology to compile this guideline. This guideline formulated recommendations for oral and (or) clyster treatment of UC in different severities and goals of treatment, in order to provide normative suggestions for clinicians to rationally use Chinese patent medicines in UC.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Gastroenterology
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS